Lakefront BiotherapeuticsGLPGF
13F holders, Q2 2025 (June 30)1holders
$27.99avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Lakefront Biotherapeutics (GLPGF) in their 13F filings. The largest holder was Old Mission Capital LLC ($1.3M).
- Company
- Lakefront Biotherapeutics
- Filed as
- GALAPAGOS NV-SPON ADR (Q2 2025)
- CUSIP
- B44170106
- Latest filing quarter
- Q2 2025
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1.3M |
| Exits | 0 | $0 |
Ownership 1 holders
| Old Mission Capital LLC | 0.03% | New | 45,496 | $1.3M |
"% of holder's portfolio" is GLPGF's weight in each manager's 13F, not the share of Lakefront Biotherapeutics the manager owns.